Monia Brett P 4

What Happened

• Monia Brett P, Chief Executive Officer of Ionis Pharmaceuticals (IONS), sold 29,430 shares on 2026-02-06 in an open-market transaction for total proceeds of $2,524,820. The weighted-average sale price reported was $85.79 per share (individual trades ranged $85.22–$86.055). This was a sale (routine monetization), not a purchase.

Key Details

• Transaction date: 2026-02-06; Form 4 filed 2026-02-10 (filing appears timely).
• Price: weighted average $85.79; range $85.22 to $86.055 across multiple trades (per footnote).
• Shares sold: 29,430; proceeds: $2,524,820.
• Footnotes: sale executed pursuant to a Rule 10b5-1 trading plan adopted Aug 13, 2024; detailed per-price breakdown available upon request per filing.
• Shares owned after transaction: not specified in the summary provided here — see the filed Form 4 for current beneficial ownership details.

Context

• Sales under an established Rule 10b5-1 plan are typically pre-scheduled and can be routine (do not necessarily indicate management’s view of the company’s near-term prospects).
• For retail investors: purchases by insiders often carry more immediate informational weight than routine sales, but tracking patterns of insider buying/selling over time can still be informative.